Meddoc

Quick facts

Phase 2 pipeline

• BP-C2 · Cardiovascular
  BP-C2 is a small molecule that targets the renin-angiotensin system to lower blood pressure.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Meddoc portfolio CI brief
• Meddoc pipeline updates RSS